The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
A glaucoma drainage implant is a small device placed in the eye to treat glaucoma. There are many different ways to treat glaucoma. In addition to conventional and laser surgery, there are a variety of drugs to lower intraocular pressure (IOP). If these methods alone fail, doctors may suggest implants.
Highlights
The global Implantable Glaucoma Device market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Implantable Glaucoma Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Implantable Glaucoma Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of Implantable Glaucoma Device include AbbVie, Santen Pharmaceutical, Johnson and Johnson, Advanced Ophthalmic Innovations (AOI), New World Medical, Glaukos Corp, Ocular Therapeutix and PolyActiva, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
The global market for Implantable Glaucoma Device in Hospital is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Valved Drainage Implants, which accounted for % of the global market of Implantable Glaucoma Device in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Implantable Glaucoma Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Glaucoma Device.
The Implantable Glaucoma Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Implantable Glaucoma Device market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Implantable Glaucoma Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- AbbVie
- Santen Pharmaceutical
- Johnson and Johnson
- Advanced Ophthalmic Innovations (AOI)
- New World Medical
- Glaukos Corp
- Ocular Therapeutix
- PolyActiva
Product Type Insights
Global markets are presented by Implantable Glaucoma Device type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Implantable Glaucoma Device are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Implantable Glaucoma Device segment by Type
- Valved Drainage Implants
- Non-valved Drainage Implants
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Implantable Glaucoma Device market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Implantable Glaucoma Device market.
Implantable Glaucoma Device segment by Application
- Hospital
- Ophthalmology Clinics
- Ambulatory Surgery Centers
- Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina, Colombia)
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Implantable Glaucoma Device market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
- This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Implantable Glaucoma Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
- This report will help stakeholders to understand the global industry status and trends of Implantable Glaucoma Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
- This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
- This report stays updated with novel technology integration, features, and the latest developments in the market
- This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Implantable Glaucoma Device industry.
- This report helps stakeholders to gain insights into which regions to target globally
- This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Implantable Glaucoma Device.
- This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Implantable Glaucoma Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Implantable Glaucoma Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
Index
1 Implantable Glaucoma Device Market Overview
1.1 Product Overview and Scope of Implantable Glaucoma Device
1.2 Implantable Glaucoma Device Segment by Type
1.2.1 Global Implantable Glaucoma Device Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Valved Drainage Implants
1.2.3 Non-valved Drainage Implants
1.3 Implantable Glaucoma Device Segment by Application
1.3.1 Global Implantable Glaucoma Device Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Ophthalmology Clinics
1.3.4 Ambulatory Surgery Centers
1.3.5 Others
1.4 Global Implantable Glaucoma Device Market Size Estimates and Forecasts
1.4.1 Global Implantable Glaucoma Device Revenue 2017-2028
1.4.2 Global Implantable Glaucoma Device Sales 2017-2028
1.4.3 Implantable Glaucoma Device Market Size by Region: 2017 Versus 2021 Versus 2028
2 Implantable Glaucoma Device Market Competition by Manufacturers
2.1 Global Implantable Glaucoma Device Sales Market Share by Manufacturers (2017-2022)
2.2 Global Implantable Glaucoma Device Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Implantable Glaucoma Device Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Implantable Glaucoma Device Manufacturing Sites, Area Served, Product Type
2.5 Implantable Glaucoma Device Market Competitive Situation and Trends
2.5.1 Implantable Glaucoma Device Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Implantable Glaucoma Device Players Market Share by Revenue
2.5.3 Global Implantable Glaucoma Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Implantable Glaucoma Device Retrospective Market Scenario by Region
3.1 Global Implantable Glaucoma Device Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Implantable Glaucoma Device Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Implantable Glaucoma Device Market Facts & Figures by Country
3.3.1 North America Implantable Glaucoma Device Sales by Country
3.3.2 North America Implantable Glaucoma Device Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Implantable Glaucoma Device Market Facts & Figures by Country
3.4.1 Europe Implantable Glaucoma Device Sales by Country
3.4.2 Europe Implantable Glaucoma Device Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Implantable Glaucoma Device Market Facts & Figures by Region
3.5.1 Asia Pacific Implantable Glaucoma Device Sales by Region
3.5.2 Asia Pacific Implantable Glaucoma Device Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Implantable Glaucoma Device Market Facts & Figures by Country
3.6.1 Latin America Implantable Glaucoma Device Sales by Country
3.6.2 Latin America Implantable Glaucoma Device Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Implantable Glaucoma Device Market Facts & Figures by Country
3.7.1 Middle East and Africa Implantable Glaucoma Device Sales by Country
3.7.2 Middle East and Africa Implantable Glaucoma Device Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Implantable Glaucoma Device Historic Market Analysis by Type
4.1 Global Implantable Glaucoma Device Sales Market Share by Type (2017-2022)
4.2 Global Implantable Glaucoma Device Revenue Market Share by Type (2017-2022)
4.3 Global Implantable Glaucoma Device Price by Type (2017-2022)
5 Global Implantable Glaucoma Device Historic Market Analysis by Application
5.1 Global Implantable Glaucoma Device Sales Market Share by Application (2017-2022)
5.2 Global Implantable Glaucoma Device Revenue Market Share by Application (2017-2022)
5.3 Global Implantable Glaucoma Device Price by Application (2017-2022)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Implantable Glaucoma Device Sales, Revenue and Gross Margin (2017-2022)
6.1.4 AbbVie Implantable Glaucoma Device Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Santen Pharmaceutical
6.2.1 Santen Pharmaceutical Corporation Information
6.2.2 Santen Pharmaceutical Description and Business Overview
6.2.3 Santen Pharmaceutical Implantable Glaucoma Device Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Santen Pharmaceutical Implantable Glaucoma Device Product Portfolio
6.2.5 Santen Pharmaceutical Recent Developments/Updates
6.3 Johnson and Johnson
6.3.1 Johnson and Johnson Corporation Information
6.3.2 Johnson and Johnson Description and Business Overview
6.3.3 Johnson and Johnson Implantable Glaucoma Device Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Johnson and Johnson Implantable Glaucoma Device Product Portfolio
6.3.5 Johnson and Johnson Recent Developments/Updates
6.4 Advanced Ophthalmic Innovations (AOI)
6.4.1 Advanced Ophthalmic Innovations (AOI) Corporation Information
6.4.2 Advanced Ophthalmic Innovations (AOI) Description and Business Overview
6.4.3 Advanced Ophthalmic Innovations (AOI) Implantable Glaucoma Device Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Advanced Ophthalmic Innovations (AOI) Implantable Glaucoma Device Product Portfolio
6.4.5 Advanced Ophthalmic Innovations (AOI) Recent Developments/Updates
6.5 New World Medical
6.5.1 New World Medical Corporation Information
6.5.2 New World Medical Description and Business Overview
6.5.3 New World Medical Implantable Glaucoma Device Sales, Revenue and Gross Margin (2017-2022)
6.5.4 New World Medical Implantable Glaucoma Device Product Portfolio
6.5.5 New World Medical Recent Developments/Updates
6.6 Glaukos Corp
6.6.1 Glaukos Corp Corporation Information
6.6.2 Glaukos Corp Description and Business Overview
6.6.3 Glaukos Corp Implantable Glaucoma Device Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Glaukos Corp Implantable Glaucoma Device Product Portfolio
6.6.5 Glaukos Corp Recent Developments/Updates
6.7 Ocular Therapeutix
6.6.1 Ocular Therapeutix Corporation Information
6.6.2 Ocular Therapeutix Description and Business Overview
6.6.3 Ocular Therapeutix Implantable Glaucoma Device Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Ocular Therapeutix Implantable Glaucoma Device Product Portfolio
6.7.5 Ocular Therapeutix Recent Developments/Updates
6.8 PolyActiva
6.8.1 PolyActiva Corporation Information
6.8.2 PolyActiva Description and Business Overview
6.8.3 PolyActiva Implantable Glaucoma Device Sales, Revenue and Gross Margin (2017-2022)
6.8.4 PolyActiva Implantable Glaucoma Device Product Portfolio
6.8.5 PolyActiva Recent Developments/Updates
7 Implantable Glaucoma Device Manufacturing Cost Analysis
7.1 Implantable Glaucoma Device Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Implantable Glaucoma Device
7.4 Implantable Glaucoma Device Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Implantable Glaucoma Device Distributors List
8.3 Implantable Glaucoma Device Customers
9 Implantable Glaucoma Device Market Dynamics
9.1 Implantable Glaucoma Device Industry Trends
9.2 Implantable Glaucoma Device Market Drivers
9.3 Implantable Glaucoma Device Market Challenges
9.4 Implantable Glaucoma Device Market Restraints
10 Global Market Forecast
10.1 Implantable Glaucoma Device Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Implantable Glaucoma Device by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Implantable Glaucoma Device by Type (2023-2028)
10.2 Implantable Glaucoma Device Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Implantable Glaucoma Device by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Implantable Glaucoma Device by Application (2023-2028)
10.3 Implantable Glaucoma Device Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Implantable Glaucoma Device by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Implantable Glaucoma Device by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Implantable Glaucoma Device Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Implantable Glaucoma Device Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Implantable Glaucoma Device Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Implantable Glaucoma Device Market Competitive Situation by Manufacturers in 2021
Table 5. Global Implantable Glaucoma Device Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Implantable Glaucoma Device Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Implantable Glaucoma Device Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Implantable Glaucoma Device Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Implantable Glaucoma Device Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Implantable Glaucoma Device Manufacturing Sites and Area Served
Table 11. Manufacturers Implantable Glaucoma Device Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Implantable Glaucoma Device by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Implantable Glaucoma Device as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Implantable Glaucoma Device Sales by Region (2017-2022) & (K Units)
Table 16. Global Implantable Glaucoma Device Sales Market Share by Region (2017-2022)
Table 17. Global Implantable Glaucoma Device Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Implantable Glaucoma Device Revenue Market Share by Region (2017-2022)
Table 19. North America Implantable Glaucoma Device Sales by Country (2017-2022) & (K Units)
Table 20. North America Implantable Glaucoma Device Sales Market Share by Country (2017-2022)
Table 21. North America Implantable Glaucoma Device Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Implantable Glaucoma Device Revenue Market Share by Country (2017-2022)
Table 23. Europe Implantable Glaucoma Device Sales by Country (2017-2022) & (K Units)
Table 24. Europe Implantable Glaucoma Device Sales Market Share by Country (2017-2022)
Table 25. Europe Implantable Glaucoma Device Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Implantable Glaucoma Device Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Implantable Glaucoma Device Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Implantable Glaucoma Device Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Implantable Glaucoma Device Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Implantable Glaucoma Device Revenue Market Share by Region (2017-2022)
Table 31. Latin America Implantable Glaucoma Device Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Implantable Glaucoma Device Sales Market Share by Country (2017-2022)
Table 33. Latin America Implantable Glaucoma Device Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Implantable Glaucoma Device Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Implantable Glaucoma Device Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Implantable Glaucoma Device Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Implantable Glaucoma Device Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Implantable Glaucoma Device Revenue Market Share by Country (2017-2022)
Table 39. Global Implantable Glaucoma Device Sales by Type (2017-2022) & (K Units)
Table 40. Global Implantable Glaucoma Device Sales Market Share by Type (2017-2022)
Table 41. Global Implantable Glaucoma Device Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Implantable Glaucoma Device Revenue Share by Type (2017-2022)
Table 43. Global Implantable Glaucoma Device Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Implantable Glaucoma Device Sales (K Units) by Application (2017-2022)
Table 45. Global Implantable Glaucoma Device Sales Market Share by Application (2017-2022)
Table 46. Global Implantable Glaucoma Device Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Implantable Glaucoma Device Revenue Share by Application (2017-2022)
Table 48. Global Implantable Glaucoma Device Price by Application (2017-2022) & (US$/Unit)
Table 49. AbbVie Corporation Information
Table 50. AbbVie Description and Business Overview
Table 51. AbbVie Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. AbbVie Implantable Glaucoma Device Product
Table 53. AbbVie Recent Developments/Updates
Table 54. Santen Pharmaceutical Corporation Information
Table 55. Santen Pharmaceutical Description and Business Overview
Table 56. Santen Pharmaceutical Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Santen Pharmaceutical Implantable Glaucoma Device Product
Table 58. Santen Pharmaceutical Recent Developments/Updates
Table 59. Johnson and Johnson Corporation Information
Table 60. Johnson and Johnson Description and Business Overview
Table 61. Johnson and Johnson Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Johnson and Johnson Implantable Glaucoma Device Product
Table 63. Johnson and Johnson Recent Developments/Updates
Table 64. Advanced Ophthalmic Innovations (AOI) Corporation Information
Table 65. Advanced Ophthalmic Innovations (AOI) Description and Business Overview
Table 66. Advanced Ophthalmic Innovations (AOI) Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Advanced Ophthalmic Innovations (AOI) Implantable Glaucoma Device Product
Table 68. Advanced Ophthalmic Innovations (AOI) Recent Developments/Updates
Table 69. New World Medical Corporation Information
Table 70. New World Medical Description and Business Overview
Table 71. New World Medical Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. New World Medical Implantable Glaucoma Device Product
Table 73. New World Medical Recent Developments/Updates
Table 74. Glaukos Corp Corporation Information
Table 75. Glaukos Corp Description and Business Overview
Table 76. Glaukos Corp Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Glaukos Corp Implantable Glaucoma Device Product
Table 78. Glaukos Corp Recent Developments/Updates
Table 79. Ocular Therapeutix Corporation Information
Table 80. Ocular Therapeutix Description and Business Overview
Table 81. Ocular Therapeutix Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Ocular Therapeutix Implantable Glaucoma Device Product
Table 83. Ocular Therapeutix Recent Developments/Updates
Table 84. PolyActiva Corporation Information
Table 85. PolyActiva Description and Business Overview
Table 86. PolyActiva Implantable Glaucoma Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. PolyActiva Implantable Glaucoma Device Product
Table 88. PolyActiva Recent Developments/Updates
Table 89. Production Base and Market Concentration Rate of Raw Material
Table 90. Key Suppliers of Raw Materials
Table 91. Implantable Glaucoma Device Distributors List
Table 92. Implantable Glaucoma Device Customers List
Table 93. Implantable Glaucoma Device Market Trends
Table 94. Implantable Glaucoma Device Market Drivers
Table 95. Implantable Glaucoma Device Market Challenges
Table 96. Implantable Glaucoma Device Market Restraints
Table 97. Global Implantable Glaucoma Device Sales Forecast by Type (2023-2028) & (K Units)
Table 98. Global Implantable Glaucoma Device Sales Market Share Forecast by Type (2023-2028)
Table 99. Global Implantable Glaucoma Device Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 100. Global Implantable Glaucoma Device Revenue Market Share Forecast by Type (2023-2028)
Table 101. Global Implantable Glaucoma Device Sales Forecast by Application (2023-2028) & (K Units)
Table 102. Global Implantable Glaucoma Device Sales Market Share Forecast by Application (2023-2028)
Table 103. Global Implantable Glaucoma Device Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 104. Global Implantable Glaucoma Device Revenue Market Share Forecast by Application (2023-2028)
Table 105. Global Implantable Glaucoma Device Sales Forecast by Region (2023-2028) & (K Units)
Table 106. Global Implantable Glaucoma Device Sales Market Share Forecast by Region (2023-2028)
Table 107. Global Implantable Glaucoma Device Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 108. Global Implantable Glaucoma Device Revenue Market Share Forecast by Region (2023-2028)
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Implantable Glaucoma Device
Figure 2. Global Implantable Glaucoma Device Market Share by Type in 2021 & 2028
Figure 3. Valved Drainage Implants Product Picture
Figure 4. Non-valved Drainage Implants Product Picture
Figure 5. Global Implantable Glaucoma Device Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Ophthalmology Clinics
Figure 8. Ambulatory Surgery Centers
Figure 9. Others
Figure 10. Global Implantable Glaucoma Device Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Implantable Glaucoma Device Market Size (2017-2028) & (US$ Million)
Figure 12. Global Implantable Glaucoma Device Sales (2017-2028) & (K Units)
Figure 13. Implantable Glaucoma Device Sales Share by Manufacturers in 2021
Figure 14. Global Implantable Glaucoma Device Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Implantable Glaucoma Device Players: Market Share by Revenue in 2021
Figure 16. Implantable Glaucoma Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Implantable Glaucoma Device Sales Market Share by Region (2017-2022)
Figure 18. Global Implantable Glaucoma Device Sales Market Share by Region in 2021
Figure 19. Global Implantable Glaucoma Device Revenue Market Share by Region (2017-2022)
Figure 20. Global Implantable Glaucoma Device Revenue Market Share by Region in 2021
Figure 21. United States Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. China Taiwan Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Mexico Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Brazil Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Argentina Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Colombia Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE Implantable Glaucoma Device Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of Implantable Glaucoma Device by Type (2017-2022)
Figure 45. Manufacturing Cost Structure of Implantable Glaucoma Device
Figure 46. Manufacturing Process Analysis of Implantable Glaucoma Device
Figure 47. Implantable Glaucoma Device Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
